Even before the pandemic, traditional in-person clinical trials were increasing in cost and duration while struggling to recruit and retain participants. As a result, patients in rural and under-served communities were often unable to participate, which created under-represented study groups. Thanks to investments in cloud technology, IoT and AI/ML, organizations can now implement digital engagement platforms, in combination with traditional in-person visits, to decentralize studies through augmented data capture via these digital tools. This approach can improve participant experiences and increase accessibility to a broader and more diverse population.
In this webinar, learn how the Duke Heart Center launched a fully digital, decentralized clinical study leveraging Deloitte’s ConvergeHEALTH MyPath for Clinical platform powered by Amazon Web Services (AWS) to study the impact of COVID-19 on athletes’ heart health. Discover how this important study could give us insights into the impact of COVID on elite athletes, as well as the role that cloud based digital platforms can play to accelerate recruitment and improve retention and event ascertainment to augment the in-person visits that would have been required in the past.
Attend this webinar to learn:
Dr. Patel is a senior investigator for the Duke Clinical Research institute and trained in cardiac MRI, coronary and peripheral intervention. His research has included landmark clinical trials involving patients with vascular disease and in cardiac imaging. His integration of these efforts in teaching and research at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentorship Award. Most notably, his research is seminal in the improved care for patients undergoing vascular care and diagnostic coronary testing. He has published over 400 peer reviewed manuscripts and has been noted to be in the top 1% of cited researcher by Clarivate Analytics. In 2020, he was named the Distinguished Richard S. Stack Professor of Cardiology at Duke University.
Jennifer C. Goldsack co-founded and serves as the CEO of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit organization dedicated to advancing digital medicine to optimize human health. Jen’s research focuses on applied approaches to the safe, effective, and equitable use of digital technologies to improve health, healthcare, and health research. She is a member of the Roundtable on Genomics and Precision Health at the National Academies of Science, Engineering and Medicine
Lita is the Worldwide Head of Life Sciences for AWS. In this role, she works with business leaders to accelerate transformation goals across the value chain through advanced cloud-based capabilities to drive better outcomes for patients, caregivers and healthcare providers. Lita has led large-scale transformation initiatives for pharmaceutical companies such as Novartis, Pfizer and Pharmacia. Lita is a member of Clinical Trial Transformation Initiative tech advisory board, and a founding member of Digital Medicine Society.
A Managing Director at Deloitte Consulting LLP, Ryan serves as the leader of the ConvergeHEALTH Life Sciences product portfolio and the Life Sciences alliance leader for Amazon Web Services. In these roles, Ryan integrates ConvergeHEALTH’s solutions to solve clients’ issues across the value chain from research and development and real-world evidence to patient experience and value and pricing solutions. In addition, Ryan focuses on strengthening industry relationships to continue to bring innovative solutions to market.